{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:01:43Z","timestamp":1785542503475,"version":"3.56.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T00:00:00Z","timestamp":1580947200000},"content-version":"vor","delay-in-days":370,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Pechenik Montague Award Fund"},{"name":"Benaroya Award Fund"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.ymthe.2018.11.013","type":"journal-article","created":{"date-parts":[[2018,11,16]],"date-time":"2018-11-16T21:31:54Z","timestamp":1542403914000},"page":"465-478","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"title":["AAV-Mediated Progranulin Delivery to a Mouse Model of Progranulin Deficiency Causes T Cell-Mediated Toxicity"],"prefix":"10.1016","volume":"27","author":[{"given":"Defne A.","family":"Amado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julianne M.","family":"Rieders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fortunay","family":"Diatta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Hernandez-Con","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adina","family":"Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan T.","family":"Mak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junxian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Lancaster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverly L.","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice S.","family":"Chen-Plotkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2018.11.013_bib1","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/nature05016","article-title":"Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17","volume":"442","author":"Baker","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2018.11.013_bib2","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/nature05017","article-title":"Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21","volume":"442","author":"Cruts","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2018.11.013_bib3","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.ajhg.2012.04.021","article-title":"Strikingly different clinicopathological phenotypes determined by progranulin-mutation dosage","volume":"90","author":"Smith","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymthe.2018.11.013_bib4","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1017\/S1355617702814357","article-title":"Frontotemporal dementia: a review","volume":"8","author":"Grossman","year":"2002","journal-title":"J.\u00a0Int. Neuropsychol. Soc."},{"key":"10.1016\/j.ymthe.2018.11.013_bib5","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1001\/archneurol.2011.53","article-title":"Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration","volume":"68","author":"Chen-Plotkin","year":"2011","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ymthe.2018.11.013_bib6","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1111\/epi.12632","article-title":"Recurrent generalized seizures, visual loss, and palinopsia as phenotypic features of neuronal ceroid lipofuscinosis due to progranulin gene mutation","volume":"55","author":"Canafoglia","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.ymthe.2018.11.013_bib7","doi-asserted-by":"crossref","first-page":"200.e1","DOI":"10.1016\/j.neurobiolaging.2016.02.019","article-title":"Portuguese family with the co-occurrence of frontotemporal lobar degeneration and neuronal ceroid lipofuscinosis phenotypes due to progranulin gene mutation","volume":"41","author":"Almeida","year":"2016","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ymthe.2018.11.013_bib8","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/humu.21624","article-title":"Update of the mutation spectrum and clinical correlations of over 360 mutations in eight genes that underlie the neuronal ceroid lipofuscinoses","volume":"33","author":"Kousi","year":"2012","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymthe.2018.11.013_bib9","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1523\/JNEUROSCI.5757-10.2011","article-title":"Rescue of progranulin deficiency associated with frontotemporal lobar degeneration by alkalizing reagents and inhibition of vacuolar ATPase","volume":"31","author":"Capell","year":"2011","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ymthe.2018.11.013_bib10","doi-asserted-by":"crossref","first-page":"16101","DOI":"10.1074\/jbc.M110.193433","article-title":"Suberoylanilide hydroxamic acid (vorinostat) up-regulates progranulin transcription: rational therapeutic approach to frontotemporal dementia","volume":"286","author":"Cenik","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2018.11.013_bib11","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/hmg\/ddt534","article-title":"Targeted manipulation of the sortilin-progranulin axis rescues progranulin haploinsufficiency","volume":"23","author":"Lee","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2018.11.013_bib12","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s12031-011-9569-4","article-title":"Structure, function, and mechanism of progranulin; the brain and beyond","volume":"45","author":"Toh","year":"2011","journal-title":"J.\u00a0Mol. Neurosci."},{"key":"10.1016\/j.ymthe.2018.11.013_bib13","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1189\/jlb.0812429","article-title":"Insights into the role of progranulin in immunity, infection, and inflammation","volume":"93","author":"Jian","year":"2013","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.ymthe.2018.11.013_bib14","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1002\/cne.22430","article-title":"Progranulin expression in the developing and adult murine brain","volume":"518","author":"Petkau","year":"2010","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.ymthe.2018.11.013_bib15","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00401-009-0576-2","article-title":"Brain progranulin expression in GRN-associated frontotemporal lobar degeneration","volume":"119","author":"Chen-Plotkin","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ymthe.2018.11.013_bib16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1083\/jcb.200712039","article-title":"Progranulin functions as a neurotrophic factor to regulate neurite outgrowth and enhance neuronal survival","volume":"181","author":"Van Damme","year":"2008","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.ymthe.2018.11.013_bib17","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/s13238-010-0067-1","article-title":"Progranulin promotes neurite outgrowth and neuronal differentiation by regulating GSK-3\u03b2","volume":"1","author":"Gao","year":"2010","journal-title":"Protein Cell"},{"key":"10.1016\/j.ymthe.2018.11.013_bib18","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1093\/hmg\/ddx162","article-title":"Progranulin functions as a cathepsin D chaperone to stimulate axonal outgrowth in\u00a0vivo","volume":"26","author":"Beel","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2018.11.013_bib19","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.neuron.2010.09.034","article-title":"Sortilin-mediated endocytosis determines levels of the frontotemporal dementia protein, progranulin","volume":"68","author":"Hu","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.ymthe.2018.11.013_bib20","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/nm.3672","article-title":"Progranulin protects against amyloid \u03b2 deposition and toxicity in Alzheimer\u2019s disease mouse models","volume":"20","author":"Minami","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2018.11.013_bib21","doi-asserted-by":"crossref","first-page":"e0182896","DOI":"10.1371\/journal.pone.0182896","article-title":"Progranulin gene delivery reduces plaque burden and synaptic atrophy in a mouse model of Alzheimer\u2019s disease","volume":"12","author":"Van Kampen","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymthe.2018.11.013_bib22","doi-asserted-by":"crossref","first-page":"e97032","DOI":"10.1371\/journal.pone.0097032","article-title":"Progranulin gene delivery protects dopaminergic neurons in a mouse model of Parkinson\u2019s disease","volume":"9","author":"Van Kampen","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymthe.2018.11.013_bib23","doi-asserted-by":"crossref","first-page":"e13368","DOI":"10.1371\/journal.pone.0013368","article-title":"Progranulin is neurotrophic in\u00a0vivo and protects against a mutant TDP-43 induced axonopathy","volume":"5","author":"Laird","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymthe.2018.11.013_bib24","doi-asserted-by":"crossref","first-page":"e0174784","DOI":"10.1371\/journal.pone.0174784","article-title":"Neurotrophic effects of progranulin in\u00a0vivo in reversing motor neuron defects caused by over or under expression of TDP-43 or FUS","volume":"12","author":"Chitramuthu","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymthe.2018.11.013_bib25","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1093\/hmg\/dds485","article-title":"Reduction of polyglutamine toxicity by TDP-43, FUS and progranulin in Huntington\u2019s disease models","volume":"22","author":"Tauffenberger","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2018.11.013_bib26","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(17)31868-8","article-title":"Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial","volume":"390","author":"Russell","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2018.11.013_bib27","doi-asserted-by":"crossref","first-page":"eean4672","DOI":"10.1126\/science.aan4672","article-title":"Gene therapy comes of age","volume":"359","author":"Dunbar","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2018.11.013_bib28","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","article-title":"Single-dose gene-replacement therapy for spinal muscular atrophy","volume":"377","author":"Mendell","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2018.11.013_bib29","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.ymthe.2006.01.006","article-title":"Gene therapy for lysosomal storage diseases","volume":"13","author":"Sands","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2018.11.013_bib30","doi-asserted-by":"crossref","first-page":"313ra180","DOI":"10.1126\/scitranslmed.aac6191","article-title":"AAV gene transfer delays disease onset in a TPP1-deficient canine model of the late infantile form of Batten disease","volume":"7","author":"Katz","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2018.11.013_bib31","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/nm.2025","article-title":"Molecular signatures of disease brain endothelia provide new sites for CNS-directed enzyme therapy","volume":"15","author":"Chen","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2018.11.013_bib32","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ymthe.2016.11.010","article-title":"CRISPR\/Cas9 editing of the mutant huntingtin allele in\u00a0vitro and in\u00a0vivo","volume":"25","author":"Monteys","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2018.11.013_bib33","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/mt.2014.210","article-title":"Improving single injection CSF delivery of AAV9-mediated gene therapy for SMA: a dose-response study in mice and nonhuman primates","volume":"23","author":"Meyer","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2018.11.013_bib34","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1172\/JCI66778","article-title":"Whole body correction of mucopolysaccharidosis IIIA by intracerebrospinal fluid gene therapy","volume":"123","author":"Haurigot","year":"2013","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2018.11.013_bib35","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1146\/annurev-virology-101416-041936","article-title":"Overcoming the host immune response to adeno-associated virus gene delivery vectors: the race between clearance, tolerance, neutralization, and escape","volume":"4","author":"Mingozzi","year":"2017","journal-title":"Annu. Rev. Virol."},{"key":"10.1016\/j.ymthe.2018.11.013_bib36","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1089\/hum.2017.150","article-title":"Unraveling the complex story of immune responses to AAV vectors trial after trial","volume":"28","author":"Vandamme","year":"2017","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2018.11.013_bib37","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1523\/JNEUROSCI.3081-17.2018","article-title":"Progranulin gene therapy improves lysosomal dysfunction and microglial pathology associated with frontotemporal dementia and neuronal ceroid lipofuscinosis","volume":"38","author":"Arrant","year":"2018","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ymthe.2018.11.013_bib38","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1093\/brain\/awx060","article-title":"Restoring neuronal progranulin reverses deficits in a mouse model of frontotemporal dementia","volume":"140","author":"Arrant","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.ymthe.2018.11.013_bib39","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/mt.2015.6","article-title":"Adenoassociated virus serotype 9-mediated gene therapy for X-linked adrenoleukodystrophy","volume":"23","author":"Gong","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2018.11.013_bib40","doi-asserted-by":"crossref","first-page":"9321","DOI":"10.1523\/JNEUROSCI.2936-05.2005","article-title":"Functional correction of CNS phenotypes in a lysosomal storage disease model using adeno-associated virus type 4 vectors","volume":"25","author":"Liu","year":"2005","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ymthe.2018.11.013_bib41","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1038\/mt.2010.206","article-title":"AAV4-mediated expression of IGF-1 and VEGF within cellular components of the ventricular system improves survival outcome in familial ALS mice","volume":"18","author":"Dodge","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2018.11.013_bib42","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2353\/ajpath.2010.090915","article-title":"Accelerated lipofuscinosis and ubiquitination in granulin knockout mice suggest a role for progranulin in successful aging","volume":"177","author":"Ahmed","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymthe.2018.11.013_bib43","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/path.4043","article-title":"Cellular ageing, increased mortality and FTLD-TDP-associated neuropathology in progranulin knockout mice","volume":"228","author":"Wils","year":"2012","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.ymthe.2018.11.013_bib44","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.nbd.2011.08.029","article-title":"Core features of frontotemporal dementia recapitulated in progranulin knockout mice","volume":"45","author":"Ghoshal","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ymthe.2018.11.013_bib45","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00401-009-0619-8","article-title":"Astrocytes: biology and pathology","volume":"119","author":"Sofroniew","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ymthe.2018.11.013_bib46","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1212\/WNL.0b013e3182364a44","article-title":"Antibodies to metabotropic glutamate receptor 5 in the Ophelia syndrome","volume":"77","author":"Lancaster","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.ymthe.2018.11.013_bib47","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nrneurol.2012.99","article-title":"Neuronal autoantigens--pathogenesis, associated disorders and antibody testing","volume":"8","author":"Lancaster","year":"2012","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ymthe.2018.11.013_bib48","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nbt.1515","article-title":"Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes","volume":"27","author":"Foust","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2018.11.013_bib49","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1073\/pnas.97.7.3428","article-title":"Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system","volume":"97","author":"Davidson","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2018.11.013_bib50","doi-asserted-by":"crossref","first-page":"212ra161","DOI":"10.1126\/scitranslmed.3007000","article-title":"Gene transfer of human Apoe isoforms results in differential modulation of amyloid deposition and neurotoxicity in mouse brain","volume":"5","author":"Hudry","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2018.11.013_bib51","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.ymthe.2018.01.010","article-title":"Overcoming limitations inherent in sulfamidase to improve mucopolysaccharidosis IIIA gene therapy","volume":"26","author":"Chen","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2018.11.013_bib52","first-page":"1353","article-title":"Identification of a human glioma-associated growth factor gene, granulin, using differential immuno-absorption","volume":"60","author":"Liau","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2018.11.013_bib53","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1177\/1947601910375273","article-title":"A Phosphotyrosine proteomic screen identifies multiple tyrosine kinase signaling pathways aberrantly activated in malignant mesothelioma","volume":"1","author":"Menges","year":"2010","journal-title":"Genes Cancer"},{"key":"10.1016\/j.ymthe.2018.11.013_bib54","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1038\/sj.gt.3302554","article-title":"Adeno-associated virus type 4 (AAV4) targets ependyma and astrocytes in the subventricular zone and RMS","volume":"12","author":"Liu","year":"2005","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2018.11.013_bib55","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.bbr.2007.07.020","article-title":"Alteration of behavioural phenotype in mice by targeted disruption of the progranulin gene","volume":"185","author":"Kayasuga","year":"2007","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ymthe.2018.11.013_bib56","doi-asserted-by":"crossref","first-page":"e404","DOI":"10.1212\/NXI.0000000000000404","article-title":"Improving the antibody-based evaluation of autoimmune encephalitis","volume":"4","author":"McCracken","year":"2017","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001618305495?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001618305495?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:53:13Z","timestamp":1761501193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001618305495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S1525001618305495"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2018.11.013","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/308692","asserted-by":"object"}]},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AAV-Mediated Progranulin Delivery to a Mouse Model of Progranulin Deficiency Causes T Cell-Mediated Toxicity","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2018.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}